New hope for liver disease patients unresponsive to standard drugs

NCT ID NCT05104853

First seen Mar 12, 2026 · Last updated Apr 26, 2026 · Updated 9 times

Summary

This study tested a new medicine called CNP-104 in 42 adults aged 18-75 with primary biliary cholangitis, a chronic liver disease. Participants were not helped enough by standard treatments. The goal was to check if CNP-104 is safe and can control the disease. The study lasted about 2 years, including follow-up.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cleveland Clinic - Florida

    Weston, Florida, 33331, United States

  • Digestive Healthcare of Georgia

    Atlanta, Georgia, 30309, United States

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Florida Research Institute

    Lakewood Rch, Florida, 34211-4930, United States

  • GI PROS Research

    Naples, Florida, 34102, United States

  • Henry Ford Health System

    Novi, Michigan, 48377, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic Florida

    Jacksonville, Florida, 32224, United States

  • Montefiore Medical Center

    The Bronx, New York, 10467, United States

  • OM Research

    Lancaster, California, 93534, United States

  • Peak Gastroenterology Associates

    Colorado Springs, Colorado, 80907, United States

  • Southern California Research Center

    Coronado, California, 92118, United States

  • Texas Liver Institute

    San Antonio, Texas, 78215, United States

  • University of California Davis Health

    Sacramento, California, 95817, United States

  • University of Chicago Medical Center

    Chicago, Illinois, 60637, United States

  • University of Florida - Hepatology Research

    Gainesville, Florida, 32610, United States

  • University of Virginia

    Charlottesville, Virginia, 22903, United States

  • Washington University School of Medicine in St. Louis

    St Louis, Missouri, 63110, United States

  • Yale School of Medicine

    New Haven, Connecticut, 06520, United States

Conditions

Explore the condition pages connected to this study.